AI joins radiologists in massive liver tumor diagnosis trial
NCT ID NCT07153783
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This large completed trial tested whether an AI system can help radiologists better diagnose liver tumors from CT scans. Over 10,000 adults with various liver conditions participated. The AI analyzed scans overnight, and a senior radiologist reviewed any differences between the AI and the initial report. The goal was to see if this teamwork improves diagnostic accuracy in real-world hospital settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-human collaborative diagnostic system for contrast-enhanced CT scans
- What this could lead to
- If successful, this could show that AI helps radiologists diagnose liver tumors more accurately and efficiently in real-world settings.
- What could go wrong
- This is a completed trial, but results are not yet published. The AI may not perform as well in practice as in earlier studies, and it may not work for all types of liver lesions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spirulina's secret protein may shield the liver during surgery
- Can a 'No-Touch' microwave technique match surgery for liver tumors?
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- AI-Powered surveillance may outsmart liver cancer recurrence
- Blood markers may forecast liver cancer treatment success
- Can a diabetes drug help fight liver cancer? a trial puts it to the test